Paper10691696
A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.
Qiu J and 1 other. J Med Chem, 2000. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase. Papers, record 10691696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691696
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Aminobutyrate Transaminase | Major topic |
| Enzyme Inhibitors | Major topic |
| Pentanoic Acids | Major topic |
| Kinetics | |
| Stereoisomerism | |
| Structure-Activity Relationship |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NS 15703 | NINDS NIH HHS | United States | R01NS015703 | PubMed and NIH |
Source NIH RePORTER
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42041309 | TXA11114: Discovery of an In Vivo Efficacious Efflux Pump Inhibitor (EPI) That Potentiates Levofloxacin Against Pseudomonas aeruginosa. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42041309 | PubMed |
| 36826597 | Identification of novel C-15 fluoro isosteviol derivatives for GABA-AT inhibition by in silico investigations. | J Mol Model | 2023 | https://conductscience.org/library/papers/36826597 | PubMed |
| 36770800 | Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3S,4S)-3-Amino-4-fluorocyclopentenecarboxylic Acid. | Molecules | 2023 | https://conductscience.org/library/papers/36770800 | PubMed |
| 35133031 | Asymmetric Synthesis of Heterocyclic Chloroamines and Aziridines by Enantioselective Protonation of Catalytically Generated Enamines. | Chemistry | 2022 | https://conductscience.org/library/papers/35133031 | PubMed |
| 34097381 | Turnover and Inactivation Mechanisms for (S)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/34097381 | PubMed |
| 33735567 | Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/33735567 | PubMed |
| 33144742 | Synthesis of complex unnatural fluorine-containing amino acids. | J Fluor Chem | 2020 | https://conductscience.org/library/papers/33144742 | PubMed |
| 33062178 | Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/33062178 | PubMed |
| 32114761 | A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/32114761 | PubMed |
| 30009604 | Synthesis of ( S)-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase. | Org Lett | 2018 | https://conductscience.org/library/papers/30009604 | PubMed |
| 29569907 | Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions. | Chem Rev | 2018 | https://conductscience.org/library/papers/29569907 | PubMed |
| 24416631 | Chiral β-Iodoamines by Urea-Catalyzed Iodocyclization of Trichloroacetimidates. | Chem Sci J | 2013 | https://conductscience.org/library/papers/24416631 | PubMed |
| 23828735 | Catalytic Aminohalogenation of Alkenes and Alkynes. | ACS Catal | 2013 | https://conductscience.org/library/papers/23828735 | PubMed |
| 22944334 | Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase. | Bioorg Med Chem | 2012 | https://conductscience.org/library/papers/22944334 | PubMed |
| 22392873 | Catalytic enantioselective alkene aminohalogenation/cyclization involving atom transfer. | Angew Chem Int Ed Engl | 2012 | https://conductscience.org/library/papers/22392873 | PubMed |
| 21201389 | N-(2-Chloro-2-nitro-1-phenyl-prop-yl)-4-methyl-benzene-sulfonamide. | Acta Crystallogr Sect E Struct Rep Online | 2008 | https://conductscience.org/library/papers/21201389 | PubMed |
| 20300507 | Diastereoselective functionalisation of benzo-annulated bicyclic sultams: Application for the synthesis of cis-2,4-diarylpyrrolidines. | Beilstein J Org Chem | 2009 | https://conductscience.org/library/papers/20300507 | PubMed |
| 17988152 | Enantiomers of 4-amino-3-fluorobutanoic acid as substrates for gamma-aminobutyric acid aminotransferase. Conformational probes for GABA binding. | Biochemistry | 2007 | https://conductscience.org/library/papers/17988152 | PubMed |
| 17267220 | Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17267220 | PubMed |
| 17149870 | Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors. | J Med Chem | 2006 | https://conductscience.org/library/papers/17149870 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABAT | 18 | PubTator's text mining | https://conductscience.org/library/genes/18 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10691696
GET https://conductscience.org/api/papers/v1/10691696/cited_by?page=2